Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies
ABSTRACTMonoclonal antibody (mAb) production using non-human cells can introduce non-human glycan epitopes including terminal galactosyl-α1–3-galactose (α1–3-Gal) moieties. Cetuximab is a commercial mAb associated with causing anaphylaxis in some patients due to the binding of endogenous anti-α1–3-G...
Main Authors: | Grayson Hatfield, Lioudmila Tepliakova, Jessica Tran, Huixin Lu, Michel Gilbert, Roger Y. Tam |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2239405 |
Similar Items
-
Human Natural Antibodies Recognizing Glycan Galβ1-3GlcNAc (Le<sup>C</sup>)
by: Kira Dobrochaeva, et al.
Published: (2020-09-01) -
Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat
by: Scott P. Commins, et al.
Published: (2016-01-01) -
Course of IgE to α‐Gal in a Swedish population of α‐Gal syndrome patients
by: Danijela Apostolovic, et al.
Published: (2021-12-01) -
Environmental and Molecular Drivers of the α-Gal Syndrome
by: Alejandro Cabezas-Cruz, et al.
Published: (2019-05-01) -
The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota
by: Daniel Bello-Gil, et al.
Published: (2019-03-01)